Skip to main content
ISO 10993-5 Complete Self-Assessment

ISO 10993-5 Complete Self-Assessment

USD257.47
Availability:
Downloadable Resources, Instant Access
Adding to cart… The item has been added

What does the ISO 10993-5 Complete Self-Assessment include?

The ISO 10993-5 Complete Self-Assessment includes a 615-question Excel dashboard, a 187-page PDF guide with ISO clause references, pre-built gap analysis matrices, remediation roadmaps, benchmarking criteria, and a full suite of 60 downloadable PDF and XLSX files, delivered by email within 24 business hours. These include self-assessments, implementation playbooks, audit kits, KPI dashboards, and Platinum Tier resources such as a 90-day roadmap, control strategy playbook, and auditor response runbook.

Are you risking regulatory rejection, clinical delays, or costly post-market recalls because your ISO 10993-5 biocompatibility evaluation lacks audit-ready rigour, comprehensive coverage, or defensible documentation? The ISO 10993-5 Complete Self-Assessment is a professional-grade digital playbook that equips you with a fully structured, clause-by-clause evaluation system to validate biological safety compliance with ISO 10993-5:2017 and ISO 10993-1:2018, ensuring your medical device clears preclinical hurdles, satisfies notified body scrutiny, and avoids the financial and reputational damage of non-conformance findings during EU MDR or FDA submissions.

What You Receive

  • A 615-question Excel Self-Assessment Dashboard (XLSX) with automated scoring and conditional logic, mapped across all seven ISO 10993-5 biological endpoints: Cytotoxicity, Irritation, Sensitisation, Systemic Toxicity, Genotoxicity, Carcinogenicity, and Implantation, enabling you to audit your current compliance posture, identify data gaps, and justify testing rationale in under 90 minutes
  • A 187-page PDF Master Guide with full question context, direct references to ISO 10993-5:2017 and ISO 10993-1:2018 clauses, scoring rubrics, and auditor-ready interpretation frameworks, so you can defend your biocompatibility rationale to regulatory bodies, internal governance panels, or quality auditors
  • Pre-built gap analysis matrices (XLSX) that correlate your device’s material composition, contact duration, and anatomical exposure pathway with required biological tests, eliminating guesswork and ensuring alignment with EU MDR Annex I, FDA Blue Book Memorandum, and MDSAP expectations
  • Remediation roadmap templates (XLSX) with RACI assignments, milestone tracking, and verification criteria, transforming assessment findings into a prioritised, executable action plan for your toxicology, R&D, and quality teams
  • Regulatory benchmarking criteria derived from actual CE marking and 510(k) submissions, so you can compare your data package against real-world approval thresholds and avoid unnecessary testing
  • 00_Platinum_Tier deliverables: a 90-day ISO 10993 implementation roadmap (XLSX), a master biocompatibility control strategy playbook (PDF), a non-conformance risk handler matrix (XLSX), an auditor response runbook (PDF), and an outcomes observability dashboard (XLSX), giving you enterprise-grade compliance architecture from day one
  • Full suite of 01_Getting_Started onboarding guides, 02_Self_Assessment_and_Diagnostics tools, 03_Requirements_and_Goal_Setting templates, 04_Models_and_Frameworks decision matrices, 06_Processes_and_Execution playbooks (14 files), 07_Performance_and_KPIs dashboards, 08_Quality_and_Governance audit kits, 09_Sustainment_and_Improvement loops, 10_Advanced_Topics case libraries, and 11_Reference_and_Quick_Cards, all in PDF and XLSX formats
  • Immediate email delivery within 24 business hours of purchase, providing instant access to approximately 60 ready-to-use files: 32 XLSX spreadsheets (including calculators, scorecards, and working models) and 28 PDF guides (including runbooks, briefings, and implementation playbooks), structured in a standardised folder system for rapid deployment

How This Helps You

This Self-Assessment ensures you can systematically validate biological safety requirements, so you avoid failed audits, regulatory delays, or mandatory redesigns that cost six figures or more. With complete clause traceability, automated gap detection, and auditor-justifiable documentation, you reduce time-to-submission by up to 40% and eliminate the risk of last-minute testing demands from notified bodies. By implementing a structured assessment framework, you future-proof your device development lifecycle, strengthen your technical file, and gain confidence that your biocompatibility strategy meets global regulatory expectations, today and as standards evolve.

Who Is This For?

  • Medical device regulatory affairs specialists preparing 510(k), CE marking, or MDSAP submissions
  • Biocompatibility engineers validating cytotoxicity, sensitisation, or genotoxicity test strategies
  • Quality managers responsible for ISO 13485 and MDR compliance documentation
  • R&D leads designing novel materials or surface treatments requiring biological evaluation
  • Toxicologists building data packages to support implantable or long-term contact devices
  • Notified body liaison officers needing defensible, standards-aligned justification for biological endpoints

Choosing not to implement a structured, standards-aligned biocompatibility assessment isn’t saving time, it’s accumulating risk. The smart professional decision is to act now with a systemised, audit-ready framework that ensures every biological safety requirement is evaluated, documented, and defensible.

!